October 01, 2026

Barings Supports Gilde Healthcare’s Expansion of Surgical Precision Instruments

Barings, one of the world’s leading global alternative investment managers, today announced that it acted as lead lender on senior secured financing for Surgical Precision Instruments GmbH (“SPI”), a MedTech contract development and manufacturing group backed by Gilde Healthcare. The financing supported SPI’s acquisitions of Hermann Medizintechnik (“Hermann”) and BENTEC Endoscopy (“BENTEC”), refinanced existing facilities and provides additional capacity for further growth.

The acquisitions significantly expand SPI’s scale and capabilities. BENTEC adds complementary manufacturing expertise in flexible and semi-flexible endoscopy instruments and Hermann broadens the group’s manufacturing capacity and capabilities in  implant systems and customised surgical instruments. Following the acquisitions, SPI has more than 500 employees across seven sites in the DACH region, with sales approaching €100 million.

SPI brings together specialist manufacturers serving medical device companies across neurosurgery, minimally invasive surgery, robotics and orthopaedics. Gilde Healthcare has built the group through the acquisitions of Chr. Diener, Koscher & Würtz, Rudischhauser, BENTEC and Hermann, and intends to continue its expansion through organic growth and strategic acquisitions.

About Barings
Barings is a $502 billion* global alternative asset manager that partners with institutional, insurance and wealth clients and supports leading businesses with flexible financing solutions. The firm, a subsidiary of MassMutual with a minority investment from MS&AD, seeks to deliver excess returns by leveraging its global scale and capabilities across credit, real assets, capital solutions and emerging markets.

*As of June 30, 2026

About Gilde Healthcare
Gilde Healthcare is a specialist investor managing over €3.8 billion across three strategies: Venture & Growth in Healthcare, Private Equity in Healthcare and Private Equity in Climate Solutions. Its healthcare private equity strategy invests in profitable lower-mid-market companies in North-Western Europe.

26-5972279

Important Information

The document is for informational purposes only and is not an offer or solicitation for the purchase or sale of any financial instrument or service in any jurisdiction. The material herein was prepared without any consideration of the investment objectives, financial situation or particular needs of anyone who may receive it. This document is not, and must not be treated as, investment advice, an investment recommendation, investment research, or a recommendation about the suitability or appropriateness of any security, commodity, investment, or particular investment strategy, and must not be construed as a projection or prediction.

In making an investment decision, prospective investors must rely on their own examination of the merits and risks involved and before making any investment decision, it is recommended that prospective investors seek independent investment, legal, tax, accounting or other professional advice as appropriate.

Unless otherwise mentioned, the views contained in this document are those of Barings. These views are made in good faith in relation to the facts known at the time of preparation and are subject to change without notice. Individual portfolio management teams may hold different views than the views expressed herein and may make different investment decisions for different clients. Parts of this document may be based on information received from sources we believe to be reliable. Although every effort is taken to ensure that the information contained in this document is accurate, Barings makes no representation or warranty, express or implied, regarding the accuracy, completeness or adequacy of the information.

Any forecasts in this material are based upon Barings opinion of the market at the date of preparation and are subject to change without notice, dependent upon many factors. Any prediction, projection or forecast is not necessarily indicative of the future or likely performance. Investment involves risk. The value of any investments and any income generated may go down as well as up and is not guaranteed by Barings or any other person. PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE RESULTS.

Any service, security, investment or product outlined in this document may not be suitable for a prospective investor or available in their jurisdiction.

Copyright and Trademark

Copyright ©2025 Barings. Information in this document may be used for your own personal use, but may not be altered, reproduced or distributed without Barings’ consent. The BARINGS name and logo design are trademarks of Barings and are registered in U.S. Patent and Trademark Office and in other countries around the world. All rights are reserved.

This document is issued in Australia by Barings Australia Pty Ltd (ACN 140 045 656, AFSL 342787).